Monarch Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.33M | Sell |
1,108
-22
| -2% | -$22.5K | 0.3% | 73 |
|
|
2026
Q1 | $1.04M | Sell |
1,130
-30
| -3% | -$30.4K | 0.25% | 73 |
|
|
2025
Q4 | $1.25M | Sell |
1,160
-149
| -11% | -$142K | 0.31% | 69 |
|
|
2025
Q3 | $999K | Sell |
1,309
-310
| -19% | -$231K | 0.24% | 72 |
|
|
2025
Q2 | $1.26M | Buy |
1,619
+245
| +18% | +$190K | 0.34% | 65 |
|
|
2025
Q1 | $1.13M | Buy |
1,374
+6
| +0.4% | +$4.99K | 0.32% | 65 |
|
|
2024
Q4 | $1.06M | Buy |
1,368
+206
| +18% | +$171K | 0.29% | 65 |
|
|
2024
Q3 | $1.03M | Hold |
1,162
| – | – | 0.28% | 66 |
|
|
2024
Q2 | $1.05M | Buy |
1,162
+27
| +2% | +$21.6K | 0.31% | 66 |
|
|
2024
Q1 | $883K | Buy |
1,135
+23
| +2% | +$16.4K | 0.25% | 70 |
|
|
2023
Q4 | $648K | Sell |
1,112
-14
| -1% | -$8.17K | 0.2% | 76 |
|
|
2023
Q3 | $605K | Sell |
1,126
-50
| -4% | -$25.8K | 0.19% | 74 |
|
|
2023
Q2 | $552K | Hold |
1,176
| – | – | 0.17% | 81 |
|
|
2023
Q1 | $404K | Sell |
1,176
-313
| -21% | -$106K | 0.12% | 94 |
|
|
2022
Q4 | $545K | Hold |
1,489
| – | – | 0.17% | 79 |
|
|
2022
Q3 | $481K | Sell |
1,489
-40
| -3% | -$12.7K | 0.16% | 82 |
|
|
2022
Q2 | $496K | Sell |
1,529
-20
| -1% | -$6K | 0.15% | 84 |
|
|
2022
Q1 | $444K | Hold |
1,549
| – | – | 0.12% | 92 |
|
|
2021
Q4 | $428K | Hold |
1,549
| – | – | 0.11% | 94 |
|
|
2021
Q3 | $358K | Sell |
1,549
-130
| -8% | -$32.1K | 0.1% | 98 |
|
|
2021
Q2 | $385K | Hold |
1,679
| – | – | 0.11% | 96 |
|
|
2021
Q1 | $314K | Sell |
1,679
-50
| -3% | -$9.78K | 0.09% | 96 |
|
|
2020
Q4 | $292K | Hold |
1,729
| – | – | 0.09% | 95 |
|
|
2020
Q3 | $256K | Hold |
1,729
| – | – | 0.09% | 93 |
|
|
2020
Q2 | $284K | Sell |
1,729
-646
| -27% | -$99.2K | 0.1% | 87 |
|
|
2020
Q1 | $329K | Sell |
2,375
-1,400
| -37% | -$192K | 0.13% | 81 |
|
|
2019
Q4 | $496K | Hold |
3,775
| – | – | 0.16% | 75 |
|
|
2019
Q3 | $422K | Sell |
3,775
-100
| -3% | -$11.1K | 0.15% | 76 |
|
|
2019
Q2 | $429K | Sell |
3,875
-300
| -7% | -$35.3K | 0.15% | 76 |
|
|
2019
Q1 | $542K | Sell |
4,175
-548
| -12% | -$66.6K | 0.2% | 72 |
|
|
2018
Q4 | $547K | Hold |
4,723
| – | – | 0.22% | 69 |
|
|
2018
Q3 | $507K | Sell |
4,723
-500
| -10% | -$50K | 0.18% | 74 |
|
|
2018
Q2 | $446K | Hold |
5,223
| – | – | 0.17% | 77 |
|
|
2018
Q1 | $404K | Buy |
5,223
+150
| +3% | +$12.1K | 0.16% | 76 |
|
|
2017
Q4 | $428K | Sell |
5,073
-600
| -11% | -$51.1K | 0.16% | 74 |
|
|
2017
Q3 | $485K | Hold |
5,673
| – | – | 0.18% | 71 |
|
|
2017
Q2 | $467K | Hold |
5,673
| – | – | 0.18% | 73 |
|
|
2017
Q1 | $477K | Hold |
5,673
| – | – | 0.17% | 71 |
|
|
2016
Q4 | $417K | Hold |
5,673
| – | – | 0.16% | 77 |
|
|
2016
Q3 | $455K | Hold |
5,673
| – | – | 0.17% | 73 |
|
|
2016
Q2 | $447K | Hold |
5,673
| – | – | 0.17% | 75 |
|
|
2016
Q1 | $409K | Hold |
5,673
| – | – | 0.15% | 80 |
|
|
2015
Q4 | $478K | Hold |
5,673
| – | – | 0.18% | 73 |
|
|
2015
Q3 | $475K | Sell |
5,673
-900
| -14% | -$76K | 0.19% | 73 |
|
|
2015
Q2 | $549K | Sell |
6,573
-700
| -10% | -$53.3K | 0.21% | 71 |
|
|
2015
Q1 | $528K | Hold |
7,273
| – | – | 0.2% | 73 |
|
|
2014
Q4 | $502K | Sell |
7,273
-500
| -6% | -$33.8K | 0.19% | 73 |
|
|
2014
Q3 | $504K | Sell |
7,773
-3,000
| -28% | -$190K | 0.2% | 71 |
|
|
2014
Q2 | $670K | Buy |
10,773
+333
| +3% | +$19.9K | 0.26% | 66 |
|
|
2014
Q1 | $614K | Buy |
10,440
+400
| +4% | +$22.3K | 0.24% | 67 |
|
|
2013
Q4 | $512K | Hold |
10,040
| – | – | 0.2% | 66 |
|
|
2013
Q3 | $505K | Sell |
10,040
-600
| -6% | -$31.4K | 0.21% | 66 |
|
|
2013
Q2 | $523K | Buy |
+10,640
| New | +$579K | 0.23% | 65 |
|
Other funds holding LLY
SC
ONB
GIM
Monarch Capital Management's LLY Position: Q2 2026 in Review
Monarch Capital Management reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $22.5K and leaving 1,108 shares worth $1.33M. The position accounts for 0.3% of the portfolio, ranked #73.
Monarch Capital Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,717 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Monarch Capital Management held 1,108 shares of Eli Lilly worth $1.33M as of Q2 2026.
- Monarch Capital Management sold 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
- Eli Lilly made up 0.3% of Monarch Capital Management's portfolio in Q2 2026, its #73 holding.
- Monarch Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 1,717 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.